What is the coverage and dosage of doxycycline for bacterial infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Doxycycline Coverage and Dosing for Bacterial Infections

Doxycycline is a broad-spectrum tetracycline antimicrobial that provides effective coverage against many bacterial pathogens, with standard adult dosing of 100 mg twice daily for most infections. 1

Antimicrobial Coverage

  • Doxycycline is effective against a wide range of bacterial pathogens, including:

    • Chlamydia trachomatis (recommended first-line treatment) 2
    • Treponema pallidum (alternative treatment for syphilis in non-pregnant patients with penicillin allergy) 2
    • Many strains of Neisseria gonorrhoeae in the United States, though not recommended as first-line due to increasing resistance 2
    • Rickettsia, Borrelia, and Ehrlichia species (drug of choice) 3
    • Respiratory pathogens causing atypical pneumonia 4
    • Many anaerobic bacteria (superior to older tetracyclines) 5
  • Doxycycline has good tissue penetration due to its lipophilic properties, allowing it to reach intracellular pathogens effectively 6

Standard Dosing Regimens

  • Adult standard dosing: 100 mg orally twice daily 1
  • Initial loading dose: For many infections, 200 mg on the first day (100 mg every 12 hours), followed by 100 mg daily maintenance dose 1
  • Pediatric dosing (>8 years old):
    • 2 mg/lb (4.4 mg/kg) divided into two doses on first day
    • 1 mg/lb (2.2 mg/kg) daily thereafter
    • For children >100 lbs, use adult dosing 1

Specific Infection Dosing

  • Sexually transmitted infections:

    • Chlamydia: 100 mg orally twice daily for 7 days 2, 1
    • Early syphilis (penicillin allergy): 100 mg orally twice daily for 2 weeks 2, 1
    • Late syphilis (>1 year duration): 100 mg orally twice daily for 4 weeks 1
    • Uncomplicated gonorrhea: 100 mg orally twice daily for 7 days 1
  • Skin and soft tissue infections:

    • Purulent cellulitis: 100 mg orally twice daily 2
    • MRSA skin infections: 100 mg orally twice daily 2
  • Other infections:

    • Malaria prophylaxis: 100 mg daily 1
    • Inhalational anthrax (post-exposure): 100 mg orally twice daily for 60 days 1
    • Lyme disease: Standard dosing (100 mg twice daily) 4

Pharmacological Considerations

  • Doxycycline has a half-life of approximately 12 hours, allowing for convenient twice-daily dosing 2, 4
  • Well absorbed orally (75% bioavailability) even with food, unlike some other tetracyclines 3
  • Primarily eliminated through hepatic and intestinal routes, making it safe for use in patients with renal impairment 1, 3
  • Should be administered with adequate fluids to reduce risk of esophageal irritation 1

Adverse Effects and Precautions

  • Most common adverse effects:

    • Photosensitivity (patients should avoid sun exposure) 2
    • Gastrointestinal symptoms including nausea, vomiting 2
    • Esophageal erosion and ulceration (take with plenty of water) 2, 1
  • Contraindications:

    • Pregnancy (category D) 2
    • Children under 8 years of age (risk of dental discoloration and bone growth inhibition) 2, 3
    • Severe liver dysfunction 3
  • Most adverse effects resolve with discontinuation of the medication 2

Clinical Pearls

  • Doxycycline can be taken with food or milk without significantly affecting absorption, which may help reduce gastrointestinal side effects 1
  • For severe infections, particularly chronic urinary tract infections, 100 mg every 12 hours is recommended 1
  • Bacterial resistance to doxycycline remains relatively low compared to many other antibiotics 3
  • When treating STIs, consider the emerging use of doxycycline as post-exposure prophylaxis (200 mg within 72 hours after sexual contact) for high-risk populations 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Doxycycline--the forgotten antibiotic].

Medizinische Klinik (Munich, Germany : 1983), 2000

Research

Tetracyclines.

The Medical clinics of North America, 1995

Research

The in-vitro activity of doxycycline and minocycline against anaerobic bacteria.

The Journal of antimicrobial chemotherapy, 1987

Research

Doxycycline in the management of sexually transmitted infections.

The Journal of antimicrobial chemotherapy, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.